Smarta Functional Medicine Expands Genetics-First Thyroid Approach for Women

The practice is expanding access to its Thyroid Genetic Blueprint, which combines genetic analysis with clinical review to help patients investigate factors that may contribute to persistent symptoms despite conventional medical treatme

United States, September 29, 2026 -- Smarta Functional Medicine, a telehealth functional medicine practice, is expanding its genetics-first thyroid approach for women who continue to experience symptoms associated with hypothyroidism or Hashimoto’s despite receiving treatment or being told that standard thyroid laboratory results are within range.

“I built this practice because I refuse to let another woman be dismissed, gaslit, or told ‘everything is fine’ when it clearly isn’t,” said Marta Banuelos, MS, CNS, LDN, Founder of Smarta Functional Medicine.

Through its Thyroid Genetic Blueprint, the practice analyzes more than 134 genes across 36 health pathways and evaluates the findings alongside a patient’s symptoms, medical history and laboratory results. The expansion is designed to give patients another structured way to investigate factors that may be relevant to thyroid function and overall health, using genetic information alongside clinical data rather than as a stand-alone diagnostic tool.

The practice is dedicated to examining genetic pathways related to thyroid hormone conversion, immune regulation, nutrient processing and other biological functions that may influence how an individual responds to treatment. The practice uses this information to help guide further assessment and personalized care planning.

The approach is aiding women searching for answers to questions such as why hypothyroid symptoms are not improving on medication, why they may have normal thyroid labs but still have symptoms, or why Hashimoto’s symptoms won’t go away despite previous interventions.

The practice’s services are structured around its Genetics First framework: rather than applying the same protocol to every patient, the practice uses genetic information as one component of individualized clinical decision-making.

For patients who have spent years moving between medications, supplements or dietary approaches without understanding why symptoms persist, this framework provides additional information that may help guide more focused conversations about future care.

“I spent nine years being told I was fine. Marta spent 30 days uncovering what genetic testing revealed, and that understanding changed how I approach my health,” said Rachel M., a Smarta Functional Medicine patient.

Another patient, Michelle D., described the information from the testing as an important part of understanding her health. “For the first time in years, I recognize myself. The information I got out of this genetics test is truly incredible.”

The practice’s expansion comes as Smarta Functional Medicine continues to focus specifically on patients whose symptoms have not been fully resolved through previous thyroid care. Its goal is to provide a more individualized assessment process that helps patients better understand what their genetics, laboratory results and clinical history may mean for their care.

Looking ahead, Smarta Functional Medicine plans to continue expanding access to its genetics-first thyroid services and personalized assessment framework, with a focus on helping more women with persistent hypothyroid and Hashimoto’s symptoms explore additional information that may be relevant to their care.



Looking ahead, Smarta Functional Medicine plans to continue expanding access to its Genetics First framework, with a focus on helping more women with persistent hypothyroid and Hashimoto’s symptoms explore additional information that may be relevant to their care.

About Smarta Functional Medicine

Smarta Functional Medicine is a Boston-based telehealth functional medicine practice led by Marta Banuelos, MS, CNS, LDN. The practice works primarily with women experiencing Hashimoto’s and persistent thyroid-related symptoms and uses a genetics-first framework alongside clinical history, bloodwork and other assessments to support individualized care planning.

Banuelos is a functional medicine practitioner and clinical nutritionist who focuses her practice on women with Hashimoto’s and persistent thyroid-related symptoms. She holds a master’s degree in Functional Medicine and Human Nutrition and has completed advanced practitioner training through the Institute for Functional Medicine.

Smarta Functional Medicine currently offers a 45-minute consultation for applicants considered suitable for the Thyroid Genetic Blueprint, during which symptoms, previous laboratory testing and clinical history can be reviewed.

For more information about the practice, refer to the contact details below.

Contact Info:
Name: Marta Banuelos
Email: Send Email
Organization: Smarta Functional Medicine
Address: 504 Beacon Street Suite 1 Boston MA 02115
Phone: 6176159198
Website: https://smartafunctionalmedicine.com/

Release ID: 89204539

If you encounter any issues, discrepancies, or concerns regarding the content provided in this press release, or if there is a need for a press release takedown, we urge you to notify us without delay at [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our expert team will be available to promptly respond within 8 hours – ensuring swift resolution of identified issues or offering guidance on removal procedures. Delivering accurate and reliable information is fundamental to our mission.